Literature DB >> 3054567

Tetanus toxin: biochemical and pharmacological comparison between its protoxin and some isotoxins obtained by limited proteolysis.

U Weller1, F Mauler, E Habermann.   

Abstract

Single-chain tetanus toxin (toxin S) was prepared from short-term cultures by lysis under protection with protease inhibitors, precipitation with 40% ammonium sulfate, gel filtration, and chromatography on DEAE ion exchanger. Its limited proteolysis by trypsin, post-arginine cleaving enzyme from mouse submaxillary gland and clostripain led to bichainal derivatives (BT, BA, BCl) consisting of a heavy chain and a larger version of the light chain. The latter was then converted by trypsin into a small version which comigrated with the light chain of bichainal extracellular toxin (BE). The light chain produced by chymotrypsin (BC) and elastase (BE1) was of intermediate size. The nick region serves as substrate for all esteroproteases investigated and comprises between one and two kDa. Limited proteolysis increased the hydrophilicity (BT greater than BE greater than S) in hydrophobic interaction HPLC, and anionic behaviour (BC greater than BE greater than BT greater than S) in DEAE ion exchanger HPLC. The bichainal toxins assessed (BC, BE or BT) were about two times more toxic than toxin S (LD50, mouse s.c. 2 ng/kg vs. 4 ng/kg). They were five to twelve times more potent than toxin S in three in vitro assays measuring the prevention of neurotransmitter release, i.e. on the phrenic nerve-hemidiaphragm preparation of the mouse (acetylcholine, with toxin BE and BT), on primary brain cell cultures from the mouse ([3H]noradrenaline, with toxin BE and BT), and on brain homogenate from rats ([3H]noradrenaline, with toxin BA, BC, BE and BT). Thus single-chain toxin is a less potent precursor of, or protoxin for, various bichainal isotoxins.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054567     DOI: 10.1007/bf00174855

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Binding of ganglioside by the chains of tetanus toxin.

Authors:  S van Heyningen
Journal:  FEBS Lett       Date:  1976-09-15       Impact factor: 4.124

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Characterization of crystalline filtrate tetanus toxin.

Authors:  W Chiu; D Rankert; M A Cumming; J P Robinson
Journal:  J Ultrastruct Res       Date:  1982-06

5.  Dissociation of tetanus neurotoxin into two polypeptide fragments.

Authors:  M Matsuda; M Yoneda
Journal:  Biochem Biophys Res Commun       Date:  1974-04-23       Impact factor: 3.575

6.  Inhibition by tetanus and botulinum A toxin of the release of [3H]noradrenaline and [3H]GABA from rat brain homogenate.

Authors:  E Habermann
Journal:  Experientia       Date:  1988-03-15

7.  Characterization of tetanus toxin binding to rat brain membranes. Evidence for a high-affinity proteinase-sensitive receptor.

Authors:  E J Pierce; M D Davison; R G Parton; W H Habig; D R Critchley
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

8.  Interaction of solid-phase gangliosides with tetanus toxin and toxoid.

Authors:  E Habermann; J L Tayot
Journal:  Toxicon       Date:  1985       Impact factor: 3.033

9.  Reevaluation of the role of gangliosides as receptors for tetanus toxin.

Authors:  D R Critchley; W H Habig; P H Fishman
Journal:  J Neurochem       Date:  1986-07       Impact factor: 5.372

10.  Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat.

Authors:  U Weller; C F Taylor; E Habermann
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

View more
  14 in total

1.  Amylase release from streptolysin O-permeabilized pancreatic acinar cells. Effects of Ca2+, guanosine 5'-[gamma-thio]triphosphate, cyclic AMP, tetanus toxin and botulinum A toxin.

Authors:  B Stecher; G Ahnert-Hilger; U Weller; T P Kemmer; M Gratzl
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Reductive cleavage of tetanus toxin and botulinum neurotoxin A by the thioredoxin system from brain. Evidence for two redox isomers of tetanus toxin.

Authors:  A Kistner; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

3.  Proteolytic fragmentation of tetanus toxin by subcellular fractions of JY, a B lymphoblastoid cell line.

Authors:  A Reboul; J Arvieux; J F Wright; M G Colomb
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

4.  Limited proteolysis of single-chain tetanus toxin by tissue enzymes, in cultured brain tissue and during retrograde axonal to the spinal cord.

Authors:  E Habermann; U Weller; M Hudel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

Review 5.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

6.  Cloning and expression of functional fragment C of tetanus toxin.

Authors:  J L Halpern; W H Habig; E A Neale; S Stibitz
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

7.  Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule.

Authors:  J Beise; J Hahnen; B Andersen-Beckh; F Dreyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-01       Impact factor: 3.000

8.  Expression of tetanus toxin subfragments in vitro and characterization of epitopes.

Authors:  B Andersen-Beckh; T Binz; H Kurazono; T Mayer; U Eisel; H Niemann
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

9.  Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells.

Authors:  E Erdal; F Bartels; T Binscheck; G Erdmann; J Frevert; A Kistner; U Weller; J Wever; H Bigalke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

10.  Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.

Authors:  D Sanders; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.